Fennec Pharmaceuticals Statistics

Total Valuation

FENC has a market cap or net worth of $136.06 million. The enterprise value is $119.07 million.

Market Cap	136.06M
Enterprise Value	119.07M

Important Dates

The last earnings date was Thursday, November 7, 2024, before market open.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

FENC has 27.43 million shares outstanding. The number of shares has increased by 2.34% in one year.

Current Share Class	27.43M
Shares Outstanding	27.43M
Shares Change (YoY)	+2.34%
Shares Change (QoQ)	+0.27%
Owned by Insiders (%)	1.66%
Owned by Institutions (%)	18.48%
Float	13.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.56
Forward PS	2.04
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	5.39
P/OCF Ratio	5.39
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2.41
EV / EBITDA	n/a
EV / EBIT	70.71
EV / FCF	5.05

Financial Position

The company has a current ratio of 7.80

Current Ratio	7.80
Quick Ratio	7.16
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	1.36
Interest Coverage	0.41

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	2.70%
Return on Capital (ROIC)	5.00%
Revenue Per Employee	$1.70M
Profits Per Employee	-$39,069
Employee Count	29
Asset Turnover	1.27
Inventory Turnover	2.22

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -44.23% in the last 52 weeks. The beta is 0.27, so FENC's price volatility has been lower than the market average.

Beta (5Y)	0.27
52-Week Price Change	-44.23%
50-Day Moving Average	4.67
200-Day Moving Average	7.08
Relative Strength Index (RSI)	53.23
Average Volume (20 Days)	127,287

Short Selling Information

The latest short interest is 1.78 million, so 6.50% of the outstanding shares have been sold short.

Short Interest	1.78M
Short Previous Month	1.84M
Short % of Shares Out	6.50%
Short % of Float	13.67%
Short Ratio (days to cover)	23.60

Income Statement

In the last 12 months, FENC had revenue of $49.35 million and -$1.13 million in losses. Loss per share was -$0.04.

Revenue	49.35M
Gross Profit	46.15M
Operating Income	1.68M
Pretax Income	3.75M
Net Income	-1.13M
EBITDA	n/a
EBIT	1.68M
Loss Per Share	-$0.04

Full Income Statement

Balance Sheet

The company has $40.32 million in cash and $32.10 million in debt, giving a net cash position of $8.22 million or $0.30 per share.

Cash & Cash Equivalents	40.32M
Total Debt	32.10M
Net Cash	8.22M
Net Cash Per Share	$0.30
Equity (Book Value)	-5.17M
Book Value Per Share	-0.19
Working Capital	50.53M

Full Balance Sheet

Cash Flow

Operating Cash Flow	23.59M
Capital Expenditures	n/a
Free Cash Flow	23.59M
FCF Per Share	$0.86

Full Cash Flow Statement

Margins

Gross margin is 93.52%, with operating and profit margins of 3.41% and -2.30%.

Gross Margin	93.52%
Operating Margin	3.41%
Pretax Margin	-2.30%
Profit Margin	-2.30%
EBITDA Margin	n/a
EBIT Margin	3.41%
FCF Margin	61.13%

Dividends & Yields

FENC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.34%
Shareholder Yield	-2.34%
Earnings Yield	-0.89%
FCF Yield	18.54%

Analyst Forecast

The average price target for FENC is $14.00, which is 182.26% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$14.00
Price Target Difference	182.26%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	50.28%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on September 5, 2014. It was a reverse split with a ratio of 0.3333333:1.

Last Split Date	Sep 5, 2014
Split Type	Reverse
Split Ratio	0.3333333:1

Scores

FENC has an Altman Z-Score of -1.17 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.17
Piotroski F-Score	5